Nivolumab Combined With Ipilimumab Treatment Induced Hypophysitis and Immune-Mediated Liver Injury in Advanced Esophageal Squamous Cell Carcinoma: A Case Report

Immune checkpoint inhibitors (ICIs) have transformed the treatment in malignancies because of the impact on reactivating the immune cells to kill tumor cells. Because anti-CTLA-4 antibody and anti-PD-1 antibody (or anti-PD-L1 antibody) work in different ways, they have synergistic effects when used...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yi, Li, Chengyang, Ji, Yuan, Liu, Ying, Gan, Lu, Yu, Yiyi, Liu, Tianshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012136/
https://www.ncbi.nlm.nih.gov/pubmed/35433482
http://dx.doi.org/10.3389/fonc.2022.801924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012136/
https://www.ncbi.nlm.nih.gov/pubmed/35433482
http://dx.doi.org/10.3389/fonc.2022.801924

Ejemplares similares